The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials.
Apr 24, 2024
0
0
Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet Neurology.
Apr 13, 2024
0
4
An international, multisite Phase III trial, co-led by a University of Cincinnati researcher, has found that a Parkinson's disease medication delivered through an infusion pump is safe and effective at reducing symptoms ...
Mar 18, 2024
0
38
Multiple sclerosis (MS) is a disease that looks different in everyone who has it—and you may know more people who have it than you think.
Mar 5, 2024
0
1
Excessive administration of analgesic drugs frequently results in medical accidents. To prevent the occurrence of these accidents, a drug infusion pump featuring a technology for safely detecting medication administration ...
Jan 30, 2024
0
0
Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large ...
Jan 29, 2024
0
0
Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects ...
Dec 13, 2023
0
22
People who drink more than three liters of fluid a day may be suffering from a rare hormone deficiency. For many, however, it is just a harmless habit. Failing to differentiate the two correctly can be fatal, so researchers ...
Nov 16, 2023
0
56
Another at-home treatment option for the flu and other respiratory illnesses is closer to becoming a reality, thanks to new research that found inhaled, monoclonal antibodies against SARS-CoV-2 significantly reduced COVID-19 ...
Nov 7, 2023
0
34
Trial results of a new drug to treat Alzheimer's disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed as a "turning point" in Alzheimer's treatment.
Jul 19, 2023
0
7
